Matteo Burroni
Global Parenteral Program Engineering Lead And Platform Owner @ Eli Lilly and Company
About Matteo Burroni
Matteo Burroni serves as the Global Parenteral Program Engineering Lead and Platform Owner at Eli Lilly and Company, where he has worked since 2018. He has extensive experience in engineering roles across various companies, focusing on parenteral program engineering and supporting the Parenteral Network and GPP Platforms for Insulin and Monoclonal Antibodies.